Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc. et al

  1. September 02, 2014

    Judge Favors Par In Novartis Alzheimer's Patch Patent Row

    A Delaware federal judge on Friday found Novartis Pharmaceuticals Corp. hadn't shown Par Pharmaceutical Inc. infringed a patent for a patch that treats Alzheimer's disease, asking the generic-name drugmaker to file a draft of a final judgment in its favor in the consolidated suit.

  2. June 18, 2014

    Judge Sides With Novartis In Dementia Patch Patent Row

    A Delaware federal judge on Wednesday found that Watson Laboratories Inc. infringed on two of Novartis Pharmaceuticals Corp.'s patents for a patch that treats Alzheimer's disease, asking the brand-name drugmaker to file a draft of a final judgment in its favor.

  3. November 04, 2011

    Novartis Fights Actavis' Generic Dementia Patch

    Pharmaceutical giant Novartis Pharmaceuticals Corp. lodged a patent infringement suit in Delaware on Thursday, seeking to stop Actavis Inc. from marketing a generic form of Novartis' Exelon patch used to treat dementia patients.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!